tiprankstipranks
Trending News
More News >
Keros Therapeutics, Inc. (KROS)
NASDAQ:KROS
US Market

Compare Keros Therapeutics (KROS) vs. Competitors

Compare
357 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Keros Therapeutics
$19.50
$575.20M
12.64
52.11%
3 Buy
4 Hold
0 Sell
Moderate Buy
Gyre Therapeutics
$6.81
$699.86M
204.46
-22.02%
2 Buy
0 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$14.94
$828.45M
-3.74
98.67%
9 Buy
0 Hold
0 Sell
Strong Buy
Palvella Therapeutics
$103.54
$1.19B
-8.21
696.46%
15 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$18.93
$1.86B
-6.38
-0.42%
15 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$17.53
$954.85M
-7.86
34.95%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KROS
Keros Therapeutics
19.50
7.02
56.25%
GYRE
Gyre Therapeutics
7.79
-2.73
-25.95%
KALV
KalVista Pharmaceuticals
14.94
7.54
101.89%
PVLA
Palvella Therapeutics
103.54
90.56
697.69%
NRIX
Nurix Therapeutics
18.93
0.33
1.77%
BCAX
Bicara Therapeutics Inc.
17.53
4.69
36.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts